Page last updated: 2024-08-26

bosentan anhydrous and Centriacinar Emphysema

bosentan anhydrous has been researched along with Centriacinar Emphysema in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, P; Chen, Y; Droma, Y; Hanaoka, M; Kubo, K; Voelkel, NF1
Chen, P; Chen, Y; Keishi, K; Masayuki, H; Peng, H; Yunden, D1
Imanishi, J; Miwa, Y; Shimizu, M; Takano, T1

Other Studies

3 other study(ies) available for bosentan anhydrous and Centriacinar Emphysema

ArticleYear
Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats.
    The European respiratory journal, 2010, Volume: 35, Issue:4

    Topics: Animals; Antihypertensive Agents; Blotting, Western; Bosentan; Caspase 3; Endothelin A Receptor Antagonists; Endothelin-1; Immunohistochemistry; In Situ Nick-End Labeling; Injections, Intraperitoneal; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Oxidative Stress; Peptides, Cyclic; Pulmonary Emphysema; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Smoking; Sulfonamides

2010
[The mechanism and pulmonary-protective effects of endothelin-1 receptor antagonist in chronic obstructive pulmonary diseases rat model].
    Zhonghua nei ke za zhi, 2010, Volume: 49, Issue:5

    Topics: Animals; Antihypertensive Agents; Apoptosis; Bosentan; Caspase 3; Endothelin A Receptor Antagonists; Interleukin-1beta; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rats, Sprague-Dawley; Sulfonamides; Tumor Necrosis Factor-alpha

2010
Disproportionate pulmonary hypertension in a patient with early-onset pulmonary emphysema treated with specific drugs for pulmonary arterial hypertension.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:20

    Topics: Adult; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Epoprostenol; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Male; Pulmonary Emphysema; Sulfonamides; Vasodilator Agents

2011